(87 days)
Not Found
Not Found
No
The summary describes a material change for dental abutments and does not mention any AI or ML components or functionalities.
No
The device, an abutment for dental implants, is a prosthetic component designed to support a dental prosthesis. It is not intended to treat or cure a disease or condition, which is the characteristic of a therapeutic device.
No
The device, an abutment for dental implants, is surgically inserted to attach a prosthesis and is not described as having any diagnostic function.
No
The device description explicitly states it is a physical component (abutment) made of a specific titanium alloy, used in dental implant surgery. It is not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the abutments are for use in "dental implant surgery" and are surgically inserted into the jawbone to support a prosthesis. This is a surgical procedure performed directly on a patient.
- Device Description: The device is a physical component (abutment) made of a specific alloy, designed to be implanted in the body.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue samples, etc.) to provide information for diagnosis, monitoring, or compatibility testing.
IVD devices are used in vitro (outside the body) to analyze biological samples. This device is used in vivo (inside the body) as a surgical implant.
N/A
Intended Use / Indications for Use
Abutments are designed for use in dental implant surgery. The 3i system includes a variety of types and sizes of specially designed bone-implantable titanium and titanium alloy implants and abutments. The implants are surgically inserted into upper and/or lower jawbones and upon healing an abutment may be placed on the implant, extending the implant's coronal aspect through the soft tissues and into the oral cavity. A prostheses is then attached to the Abutment.
A successfully osseointegrated implant will achieve a firm and direct connection between the living bone and the surface of the titanium or titanium alloy implant when surgically implanted under controlled conditions, per well known clinical studies.
Product codes (comma separated list FDA assigned to the subject device)
Not Found
Device Description
3i's various abutment systems have historically been constructed of CP Titanium per ASTM specifications. This material change covers all styles and sizes of transmucosal abutments as listed herein, and pertains exclusively to a new alloy, that will be used in the production of the abutment components; from CP Titanium, to a Titanium, Niobium, Zirconium (Ti-13Nb-13Zr).
Abutment systems include:
Standard Abutments
Emergence Profile Abutments
Conical Abutments
Pre-Angled Abutments
Temporary Screws
Tapered Abutments
Temporary Healing Abutments
Abutment Posts
Overdenture Abutments
Temporary Cylinders
Til313 is a titanium alloy consisting of Titanium, Niobium and Zirconium. Extensive physical and biological testing of the Alloy has been performed and the material is currently used in orthopedic applications. It recently received distribution clearance through the Pre-Market Notification process for 3i's Endosseous Dental Implants.
Physical testing by both the developer of Til313 and Implant Innovations, Inc. indicates an improvement in fatigue properties over commercially pure titanium which has previously been used in the construction of the transmucosal abutment and retaining screw systems.
For Abutment Systems included in this submission, there is no change in manufacturing or processing operations from those employed using the original titanium material.
Sterilization (where indicated) shall be accomplished using Co60 Irradiation, at a minimum dose of 25.0 kGy (2.5 mRads), achieving a Sterility Assurance Level (SAL) of 10(-6). Validation of sterilization process is accomplished as specified by the AAMI (Association for the Advancement of Medical Instrumentation) Guidelines and the Harmonized European Standard EN 552.
Irradiation sterilization is accomplished by an FDA registered irradiation sterilization facility.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
upper and/or lower jawbones
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Physical testing by both the developer of Til313 and Implant Innovations, Inc. indicates an improvement in fatigue properties over commercially pure titanium which has previously been used in the construction of the transmucosal abutment and retaining screw systems.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
Image /page/0/Picture/15 description: The image shows a logo with the text "3i" in bold, sans-serif font. The number "3" is larger and positioned to the left of the letter "i". A small circle is present to the right of the "i", likely indicating a registered trademark symbol. Below the "3i" logo, there is some additional text that is not clear due to the image quality.
Ka62465
3071 Continental Drive West Palm Beach, FL 33407 00-443-8166 (407) 840-2600 FAX (407) 840-2660
SEP 20 1996
Stocks Summary
510(k) SUBMISSION: MATERIAL CHANGE (ADDITION) - TITANIUM 13-NIOBIUM 13-ZIRCONIUM (Ti-13Nb-13Zr) FOR TRANSMUCOSAL ABUTMENTS FOR THE 31 ENDOSSEOUS DENTAL IMPLANT SYSTEM.
-
- CLASSIFICATION NAME: Endosseous Dental Implants
-
- COMMON/USUAL NAMES: Transmucosal Abutments and Screws, Transmucosal Elements, Abutment Cylinders and Screws, Abutments, Conical, Standard, Temporary, Tapered, etc.
-
- PROPRIETARY NAME: Standard Abutments and Screws, Conical Abutments and Screws, Emergence Profile Abutments and screws, Tapered Abutments, Temporary Healing Screws and Abutments, Posts and Cylinders, Non-Rotating Abutments, Abutment Posts, STR (Single Tooth Restoration) Abutments, "O-Ring" and "Dal-Ro" Abutments.
-
- CLASSIFICATION: Transmucosal Abutments are not in and by themselves classified. They are however, considered an integral part of the implant and are therefore classified as the implant. Endosseous dental implants, per 872.3640 have been classified as class III devices. PMA's may be required for some or all designs of endosseous dental implants including abutments, but no effective date has been established for the PMA submission.
-
- PERFORMANCE STANDARDS: Not applicable at this time.
-
- FORM: 3i's various abutment systems have historically been constructed of CP Titanium per ASTM specifications. This material change covers all styles and sizes of transmucosal abutments as listed herein, and pertains exclusively to a new alloy, that will be used in the production of the abutment components; from CP Titanium, to a Titanium, Niobium, Zirconium (Ti-13Nb-13Zr).
Abutment systems include:
| Standard Abutments | Tapered Abutments |
|---|---|
| Emergence Profile Abutments | Temporary Healing Abutments |
| Conical Abutments | Abutment Posts |
| Pre-Angled Abutments | Overdenture Abutments |
| Temporary Screws | Temporary Cylinders |
1
6a. NEW MATERIAL - Ti1313:
Til313 is a titanium alloy consisting of Titanium, Niobium and Zirconium. Extensive physical and biological testing of the Alloy has been performed and the material is currently used in orthopedic applications. It recently received distribution clearance through the Pre-Market Notification process for 3i's Endosseous Dental Implants.
Physical testing by both the developer of Til313 and Implant Innovations, Inc. indicates an improvement in fatigue properties over commercially pure titanium which has previously been used in the construction of the transmucosal abutment and retaining screw systems.
For Abutment Systems included in this submission, there is no change in manufacturing or processing operations from those employed using the original titanium material.
Sterilization (where indicated) shall be accomplished using Co60 Irradiation, at a minimum dose of 25.0 kGy (2.5 mRads), achieving a Sterility Assurance Level (SAL) of 10(-6). Validation of sterilization process is accomplished as specified by the AAMI (Association for the Advancement of Medical Instrumentation) Guidelines and the Harmonized European Standard EN 552.
Irradiation sterilization is accomplished by an FDA registered irradiation sterilization facility.
-
- LABEL/LABELING MATERIALS: The proposed material change will not necessitate revisions to device labeling or instruction sheets, other than catalog number and description, stating the new material.
-
- SUBSTANTIAL EQUIVALENCE:
The material change has not alter the previously obtained substantial equivalence determination, for the various abutment systems. This is based on the fact that there has been no change in component design, other than the proposed change to Til313, and there are no other changes in manufacturing or processing. 3i is making no claims relative to these changes at this time, and indications for use of the various abutment systems have not changed.
9. INDICATION FOR USE:
Abutments are designed for use in dental implant surgery. The 3i system includes a variety of types and sizes of specially designed bone-implantable titanium and titanium alloy implants and abutments. The implants are surgically inserted into upper and/or lower jawbones and upon
2
healing an abutment may be placed on the implant, extending the implant's coronal aspect through the soft tissues and into the oral cavity. A prostheses is then attached to the Abutment.
A successfully osseointegrated implant will achieve a firm and direct connection between the living bone and the surface of the titanium or titanium alloy implant when surgically implanted under controlled conditions, per well known clinical studies.
11. CONTRAINDICATIONS:
3i implants and Abutments should not be used in cases where the remaining jaw bone is too diminished to provide adequate width or height to surround the implant. Lack of osseointegration or subsequent implant failure may occur in cases where there is insufficient available bone or poor bone quality.
12. WARNINGS:
For safe and effective use of 3i implants and abutments, it is strongly suggested that specialized training be undertaken since the surgical techniques required to place dental implants are highly specialized and complex procedures. Improper patient selection and technique can cause implant and/or abutment failure with possible loss of supporting bone.
13. PRECAUTIONS:
Thorough screening of prospective implant candidates must be performed. Visual inspection as well as panoramic and pariapical radiographs are essential to determine anatomical landmarks, occlusal conditions, pariodontal status, and adequacy of bone. Lateral cephalometric radiographs, CT Scans, and tomograms may also be beneficial.
14. ADVERSE EFFECTS:
Loss of implant anchorage (failure to osseointegrate) and loss of the prosthesis are possible occurrences after surgery. Lack of quantity or quality of remaining bone, infections, poor patient oral hygiene or cooperation, and generalized diseases (diabetes, etc.) are some potential causes for loss of anchorage.
15. SURGICAL COMPLICATIONS:
The implant procedure has risks, including localized swelling, dehiscence, tenderness of short duration, edema, hematoma, or bleeding.
3
Numbness of the lower lip and chin region following lower jaw surgery, and of the tissue beside the nose following upper jaw surgery, is a possible side effect of the Though it would most probably be of a temporary surgery. nature, in very rare cases, the numbness has been permanent.
Gingival/Mucosal (gum tissue) ulceration, tissue reaction, or infection may occur, but generally responds to local care.
-
- PRE-MARKET NOTIFICATION CERTIFICATION AND SUMMARY FOR SUBMISSION:
I certify that I have conducted a reasonable search of all information known or otherwise available to me about the types and causes of safety and/or effectiveness problems that have been reported for Endosseous Dental Implant systems.
- PRE-MARKET NOTIFICATION CERTIFICATION AND SUMMARY FOR SUBMISSION:
Failure to osseointegrate or loss of osseointegration can be caused by improper patient selection (patients with systemic diseases which affect bone physiology, patients with habits such as bruxing or clenching, patients who are physically or psychologically unable to carry out proper implant hygiene, heavy smoking or alcohol use), by improper surgical technique (overheating of bone) or improper case planning or restorative technique (overloading of implants through improper placement, use of an insufficient number of implants or excessive cantilever). Improper implant processing by the manufacturer or improper handling by the customer, resulting in contamination, can also effect osseointegration.
Fracture of implants can occur, particularly in implants with apical cross-holes. Fracture occurs either on insertion of screw-type implants due to excessive torque (improper surgical technique such as an error in drill selection) or in service due to loss of bone.
Fracture of abutments and abutment screws occurs in implant systems and is usually attributed to factors within the control of the implant team, such as lack of passive fit of the restoration or excessive cantilever, or within the control of the patient, such as bruxing.
Other types of safety and efficacy problems which have been observed for endosseous dental implant systems are local soft tissue degeneration and bone resorption, paresthesia, perforation of the maxillary sinus, perforation of labial and lingual plates, local and systemic infection, prosthetic framework fracture, nerve injury, bone fracture, injury to adjacent teeth and their
4
supporting bone, oroantral or oronasal fistula, gingival hyperplasia, soft tissue overgrowth, perforation of the gingiva by the healing screw, mucosal abscess, displacement of the implant into the mandibular canal, hemorrhage of the floor of the mouth due to transection of the sublingual artery and breakage of drill tip, requiring surgical removal.
William G. Conety
William G/ Conety Director/ Regulatory Affairs/Quality Assurance